The heightened activation of FGF2 and IL-6 by TGF-β confined within EVs in cancer-triggered fibroblasts and mesenchymal stem cells residing in tumors suggests differences compared to free-form TGF-β[38]. The gene discussed is TGFB1; the disease is cancer.